메뉴 건너뛰기




Volumn 23, Issue 2, 2009, Pages 97-104

Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 58549116084     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.115     Document Type: Article
Times cited : (4)

References (32)
  • 1
    • 0036379472 scopus 로고    scopus 로고
    • Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study
    • Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine R et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 2002; 62: 1402-1407.
    • (2002) Kidney Int , vol.62 , pp. 1402-1407
    • Henry, R.M.A.1    Kostense, P.J.2    Bos, G.3    Dekker, J.M.4    Nijpels, G.5    Heine, R.6
  • 2
    • 0037222964 scopus 로고    scopus 로고
    • Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community
    • Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41: 47-55.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 47-55
    • Manjunath, G.1    Tighiouart, H.2    Ibrahim, H.3    MacLeod, B.4    Salem, D.N.5    Griffith, J.L.6
  • 3
    • 0033428802 scopus 로고    scopus 로고
    • Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
    • Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219.
    • (1999) Kidney Int , vol.56 , pp. 2214-2219
    • Culleton, B.F.1    Larson, M.G.2    Wilson, P.W.F.3    Evans, J.C.4    Parfrey, P.S.5    Levy, D.6
  • 4
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 5
    • 0001106451 scopus 로고    scopus 로고
    • A simplified equation to predict glomerular filtration rate from serum creatinine
    • Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.
    • (2000) J Am Soc Nephrol , vol.11
    • Levey, A.S.1    Greene, T.2    Kusek, J.W.3    Beck, G.J.4
  • 6
    • 1642502319 scopus 로고    scopus 로고
    • National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification
    • Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
    • (2003) Ann Intern Med , vol.139 , pp. 137-147
    • Levey, A.S.1    Coresh, J.2    Balk, E.3    Kausz, A.T.4    Levin, A.5    Steffes, M.W.6
  • 7
    • 23044448585 scopus 로고    scopus 로고
    • Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving global outcomes (KDIGO)
    • Levey AS, Eckardt KA, Tsukamoto Y, Levin A, Coresh J, Rossert J et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
    • (2005) Kidney Int , vol.67 , pp. 2089-2100
    • Levey, A.S.1    Eckardt, K.A.2    Tsukamoto, Y.3    Levin, A.4    Coresh, J.5    Rossert, J.6
  • 8
    • 34250350040 scopus 로고    scopus 로고
    • The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology ESC, 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-1187
    • The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-1187.
  • 9
    • 0042743790 scopus 로고    scopus 로고
    • The diabetes risk score: A practical tool to predict type 2 diabetes risk
    • Lindström J, Tuomilehto J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731.
    • (2003) Diabetes Care , vol.26 , pp. 725-731
    • Lindström, J.1    Tuomilehto, J.2
  • 10
    • 29744467894 scopus 로고    scopus 로고
    • Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values
    • Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek J et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol 2005; 16: 69A.
    • (2005) J Am Soc Nephrol , vol.16
    • Levey, A.S.1    Coresh, J.2    Greene, T.3    Marsh, J.4    Stevens, L.A.5    Kusek, J.6
  • 11
    • 35948980307 scopus 로고    scopus 로고
    • Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia
    • World Health Organization:, consultation. World Health Org, Geneva
    • World Health Organization: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. World Health Org.: Geneva, 2006.
    • (2006) Report of a WHO/IDF
  • 12
    • 25144459980 scopus 로고    scopus 로고
    • Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
    • Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
  • 13
    • 0035897696 scopus 로고    scopus 로고
    • Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel III)
    • Expert Panel on Detection
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 14
    • 33845253641 scopus 로고    scopus 로고
    • Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH Study
    • Gomez P, Ruilope LM, BarriosW, Navarro J, Prieto MA, Gonzalez O et al. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH Study. J Am Soc Nephrol 2006; 17: S194-S200.
    • (2006) J Am Soc Nephrol , vol.17
    • Gomez, P.1    Ruilope, L.M.2    Barrios, W.3    Navarro, J.4    Prieto, M.A.5    Gonzalez, O.6
  • 15
    • 33845234269 scopus 로고    scopus 로고
    • Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension
    • Redon J, Morales-Olivas F, Galgo A, Brito MA, Mediavilla J, Marín R et al. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension. J Am Soc Nephrol 2006; 17: S236-S245.
    • (2006) J Am Soc Nephrol , vol.17
    • Redon, J.1    Morales-Olivas, F.2    Galgo, A.3    Brito, M.A.4    Mediavilla, J.5    Marín, R.6
  • 16
    • 44449143917 scopus 로고    scopus 로고
    • The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease
    • Quinn MP, Rainey A, Cairns KJ, Marshall AH, Savage G, Kee F et al. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease. Nephrol Dial Transplant 2008; 23: 542-548.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 542-548
    • Quinn, M.P.1    Rainey, A.2    Cairns, K.J.3    Marshall, A.H.4    Savage, G.5    Kee, F.6
  • 17
    • 14844325792 scopus 로고    scopus 로고
    • Creatinine measurement: State of the art in accuracy and interlaboratory harmonization
    • Miller W, Myers G, Ashwood E, Killeen A, Wang E, Thienpont L et al. Creatinine measurement: State of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 2005; 129 297-304.
    • (2005) Arch Pathol Lab Med , vol.129 , pp. 297-304
    • Miller, W.1    Myers, G.2    Ashwood, E.3    Killeen, A.4    Wang, E.5    Thienpont, L.6
  • 18
    • 35848970601 scopus 로고    scopus 로고
    • In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression
    • Eriksen BO, Ingebretsen OC. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007; 72: 1242-1248.
    • (2007) Kidney Int , vol.72 , pp. 1242-1248
    • Eriksen, B.O.1    Ingebretsen, O.C.2
  • 19
    • 33645505787 scopus 로고    scopus 로고
    • on behalf of the ERIC-HTA 2003 Study. Kidney function and cardiovascular disease in the hypertensive population: The ERICHTA study
    • Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bomet A, et al., on behalf of the ERIC-HTA 2003 Study. Kidney function and cardiovascular disease in the hypertensive population: The ERICHTA study. J Hypertens 2006; 24: 663-669.
    • (2006) J Hypertens , vol.24 , pp. 663-669
    • Redón, J.1    Cea-Calvo, L.2    Lozano, J.V.3    Fernández-Pérez, C.4    Navarro, J.5    Bomet, A.6
  • 21
    • 34547660562 scopus 로고    scopus 로고
    • Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria
    • Kramer CK, Leitao CB, Pinto LC, Silveiro SP, Gross JL, Canani LH. Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria. Diabetes Care 2007; 30: 1998-2000.
    • (2007) Diabetes Care , vol.30 , pp. 1998-2000
    • Kramer, C.K.1    Leitao, C.B.2    Pinto, L.C.3    Silveiro, S.P.4    Gross, J.L.5    Canani, L.H.6
  • 23
    • 0026502417 scopus 로고
    • Glomerular number and size in relation to age, kidney weight, and body surface in normal man
    • Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992; 232: 194-201.
    • (1992) Anat Rec , vol.232 , pp. 194-201
    • Nyengaard, J.R.1    Bendtsen, T.F.2
  • 24
    • 0037248617 scopus 로고    scopus 로고
    • A stereological study of glomerular number and volume: Preliminary findings in a multiracial study of kidneys at autopsy
    • Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF. A stereological study of glomerular number and volume: Preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int 2003; 63: 531-537.
    • (2003) Kidney Int , vol.63 , pp. 531-537
    • Hoy, W.E.1    Douglas-Denton, R.N.2    Hughson, M.D.3    Cass, A.4    Johnson, K.5    Bertram, J.F.6
  • 25
    • 0037426760 scopus 로고    scopus 로고
    • Nephron number in patients with primary hypertension
    • Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108.
    • (2003) N Engl J Med , vol.348 , pp. 101-108
    • Keller, G.1    Zimmer, G.2    Mall, G.3    Ritz, E.4    Amann, K.5
  • 26
    • 27444433127 scopus 로고    scopus 로고
    • Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults
    • Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2134-2140
    • Kurella, M.1    Lo, J.C.2    Chertow, G.M.3
  • 27
    • 0028215329 scopus 로고
    • on behalf of the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease
    • Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, on behalf of the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330 878-884.
    • (1994) N Engl J Med , vol.330 , pp. 878-884
    • Klahr, S.1    Levey, A.S.2    Beck, G.J.3    Caggiula, A.W.4    Hunsicker, L.5    Kusek, J.W.6
  • 28
    • 0026012922 scopus 로고
    • Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly
    • Fletcher A, Amery A, Birgenhager W, Bulpitt C, Clement D, deLeeuw P et al. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. J Hypertens 1991; 9: 225-230.
    • (1991) J Hypertens , vol.9 , pp. 225-230
    • Fletcher, A.1    Amery, A.2    Birgenhager, W.3    Bulpitt, C.4    Clement, D.5    deLeeuw, P.6
  • 29
    • 0027326310 scopus 로고
    • Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: Final results
    • Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ et al. Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: Final results. JAMA 1993; 270: 713-724.
    • (1993) JAMA , vol.270 , pp. 713-724
    • Neaton, J.D.1    Grimm, R.H.2    Prineas, R.J.3    Stamler, J.4    Grandits, G.A.5    Elmer, P.J.6
  • 30
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
    • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
    • (2002) JAMA , vol.288 , pp. 2981-2997


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.